• 1
    Zaidel-Bar R, Itzkovitz S, Ma’ayan A, Iyengar R, Geiger B. Functional atlas of the integrin adhesome. Nat Cell Biol 2007; 9: 85867.
  • 2
    Coller BS, Shattil SJ. The GP IIb/IIIa (integrin αIIbβ3) odyssey: a technology driven saga of a receptor with twists, turns and even a bend. Blood 2008; 112: 301125.
  • 3
    Leisner TM, Yuan W, DeNofrio JC, Liu J, Parise LV. Tickling the tails: cytoplasmic domain proteins that regulate integrin αIIbβ3 activation. Curr Opin Hematol 2007; 14: 255261.
  • 4
    Bonner MA, Naik UP. Cytoplasmic binding partners of the platelet integrin αIIbβ3. Front Biosci 2007; 12: 203849.
  • 5
    Wegener KL, Partridge AW, Han J, Pickford AR, Liddington RC, Ginsberg MH, Campbell ID. Structural basis of integrin activation by talin. Cell 2007; 128: 17182.
  • 6
    Goksoy E, Ma YQ, Wang X, Kong X, Perera D, Plow EF, Qin J. Structural basis for the autoinhibition of talin in regulating integrin activation. Mol Cell 2008; 31: 12433.
  • 7
    Legate KR, Fassler R. Mechanisms that regulate adaptor binding to β-integrin cytoplasmic tails. J Cell Sci 2009; 122: 18798.
  • 8
    Denofrio JC, Yuan W, Temple BR, Gentry HR, Parise LV. Characterization of calcium- and integrin-binding protein 1 (CIB1) knockout platelets: potential compensation by CIB family members. Thromb Haemost 2008; 100: 84756.
  • 9
    Naik MU, Manrai P, Czymmek K, Nail UP. CIB1 regulates hemostasis through integrin outside-in signaling. Blood 2008; 112: 990.
  • 10
    Nieswandt B, Moser M, Pleines I, Varga-Szabo D, Monkley S, Critchley D, Fassler R. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J Exp Med 2007; 204: 31138.
  • 11
    Prevost N, Mitsios JV, Kato H, Burke JE, Dennis EA, Shimizu T, Shattil SJ. Group IVA cytosolic phospholipase A2 (cPLA2α) and integrin αIIbβ3 reinforce each other’s functions during αIIbβ3 signaling in platelets. Blood 2009; 13: 44757.
  • 12
    Chen Y-P, Djaffar I, Pidard D, Steiner B, Cieutat A-M, Caen JP, Rosa J-P. Ser-752[RIGHTWARDS ARROW]Pro mutation in the cytoplasmic domain of integrin β3 subunit and defective activation of platelet integrin αIIbβ3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 1992; 89: 1016973.
  • 13
    Wang R, Shattil SJ, Ambruso DR, Newman PJ. Truncation of the cytoplasmic domain of β3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin αIIbβ3 complex. J Clin Invest 1997; 100: 2393403.
  • 14
    Chen Y-P, O’Toole TE, Ylänne J, Rosa J-P, Ginsberg MH. A point mutation in the integrin β3 cytoplasmic domain (S752[RIGHTWARDS ARROW]>P) impairs bidirectional signaling through αΙΙββ3 (platelet glycoprotein IIb-IIIa). Blood 1994; 84: 185765.
  • 15
    Law DA, DeGuzman FR, Heiser P, Ministri-Madrid K, Killeen N, Phillips DR. Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function. Nature 1999; 401: 80811.
  • 16
    Bertagnolli ME, Locke SJ, Hensler ME, Bray PF, Beckerle MC. Talin distribution and phosphorylation in thrombin-activated platelets. J Cell Sci 1993; 106: 118999.
  • 17
    Critchley DR, Gingras AR. Talin at a glance. J Cell Sci 2008; 121: 13457.
  • 18
    Garcia-Alvarez B, De Pereda JM, Calderwood DA, Ulmer TS, Critchley D, Campbell ID, Ginsberg MH, Liddington RC. Structural determinants of integrin recognition by talin. Mol Cell 2003; 11: 4958.
  • 19
    Vinogradova O, Vaynberg J, Kong X, Haas TA, Plow EF, Qin J. Membrane-mediated structural transitions at the cytoplasmic face during integrin activation. Proc Natl Acad Sci USA 2004; 101: 40949.
  • 20
    Ulmer TS, Calderwood DA, Ginsberg MH, Campbell ID. Domain-specific interactions of talin with the membrane-proximal region of the integrin β3 subunit. Biochemistry 2003; 42: 830712.
  • 21
    Raaijmakers JH, Bos JL. Specificity in Ras and Rap signaling. J Biol Chem 2008. [Epub ahead of print].
  • 22
    Han J, Lim CJ, Watanabe N, Soriani A, Ratnikov B, Calderwood DA, Puzon-McLaughlin W, Lafuente EM, Boussiotis VA, Shattil SJ, Ginsberg MH. Reconstructing and deconstructing agonist-induced activation of integrin αIIbβ3. Curr Biol 2006; 16: 1796806.
  • 23
    Watanabe N, Bodin L, Pandey M, Krause M, Coughlin S, Boussiotis VA, Ginsberg MH, Shattil SJ. Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin αIIbβ3. J Cell Biol 2008; 181: 121122.
  • 24
    Lee HS, Lim CJ, Puzon-McLaughlin W, Shattil SJ, Ginsberg MH. RIAM activates integrins by linking talin to Ras GTPase membrane-targeting sequences. J Biol Chem December 19, 2008; DOI: 10.1074/jbc.M807117200.
  • 25
    Bergmeier W, Goerge T, Wang HW, Crittenden JR, Baldwin AC, Cifuni SM, Housman DE, Graybiel AM, Wagner DD. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest 2007; 117: 1699707.
  • 26
    Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 2005; 115: 6807.
  • 27
    Pasvolsky R, Feigelson SW, Kilic SS, Simon AJ, Tal-Lapidot G, Grabovsky V, Crittenden JR, Amariglio N, Safran M, Graybiel AM, Rechavi G, Ben-Dor S, Etzioni A, Alon R. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med 2007; 204: 157182.
  • 28
    Kuijpers TW, Van De Vijver E, Weterman MA, De Boer M, Tool AT, Van Den Berg TK, Moser M, Jakobs ME, Seeger K, Sanal O, Unal S, Cetin M, Roos D, Verhoeven AJ, Baas F. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood December 8, 2008; DOI: 10.1182/blood-2008-10-182154.
  • 29
    Petrich BG, Marchese P, Ruggeri ZM, Spiess S, Weichert RA, Ye F, Tiedt R, Skoda RC, Monkley SJ, Critchley DR, Ginsberg MH. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 2007; 204: 310311.
  • 30
    Petrich BG, Fogelstrand P, Partridge AW, Yousefi N, Ablooglu AJ, Shattil SJ, Ginsberg MH. The antithrombotic potential of selective blockade of talin-dependent integrin αIIbβ3 (platelet GPIIb-IIIa) activation. J Clin Invest 2007; 117: 22509.
  • 31
    Ussar S, Wang HV, Linder S, Fassler R, Moser M. The Kindlins: subcellular localization and expression during murine development. Exp Cell Res 2006; 312: 314251.
  • 32
    Larjava H, Plow EF, Wu C. Kindlins: essential regulators of integrin signalling and cell-matrix adhesion. EMBO Rep November 7, 2008; DOI: 10.1038/embor.2008.202.
  • 33
    Ma YQ, Qin J, Wu C, Plow EF. Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J Cell Biol 2008; 181: 43946.
  • 34
    Ussar S, Moser M, Widmaier M, Rognoni E, Harrer C, Genzel-Boroviczeny O, Fassler R. Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction. PLoS Genet 2008; 4: e1000289.
  • 35
    Moser M, Nieswandt B, Ussar S, Pozgajova M, Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008; 14: 32530.
  • 36
    Lad Y, Jiang P, Ruskamo S, Harburger DS, Ylanne J, Campbell ID, Calderwood DA. Structural basis of the migfilin-filamin interaction and competition with integrin β tails. J Biol Chem 2008; 283: 3515463.
  • 37
    Ithychanda S, Das M, Ma YQ, Ding K, Wang X, Gupta S, Wu C, Plow EF, Qin J. Migfilin: a molecular switch in regulation of integrin activation. J Biol Chem December 13, 2008; DOI: 10.1074/jbc.M807719200.
  • 38
    Abtahian F, Bezman N, Clemens R, Sebzda E, Cheng L, Shattil SJ, Kahn ML, Koretzky GA. Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol Cell Biol 2006; 26: 693649.
  • 39
    Jakus Z, Fodor S, Abram CL, Lowell CA, Mocsai A. Immunoreceptor-like signaling by β2 and β3 integrins. Trends Cell Biol 2007; 17: 493501.
  • 40
    Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ. Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets. Blood 2008; 112: 27806.
  • 41
    Shattil SJ. Integrins and Src: Dynamic duo of adhesion signaling. Trends Cell Biol 2005; 15: 399403.
  • 42
    Zou Z, Chen H, Schmaier AA, Hynes RO, Kahn ML. Structure-function analysis reveals discrete β3 integrin inside-out and outside-in signaling pathways in platelets. Blood 2007; 109: 328490.
  • 43
    Su X, Mi J, Yan J, Flevaris P, Lu Y, Liu H, Ruan Z, Wang X, Kieffer N, Chen S, Du X, Xi X. RGT, a synthetic peptide corresponding to the integrin β3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin αIIbβ3 with Src kinase. Blood 2008; 112: 592602.
  • 44
    Ablooglu AJ, Kang J, Petrich BG, Ginsberg MH, Shattil SJ. Anti-thrombotic effects of targeting αIIbβ3 signaling in platelets. Blood 2009; 113: 358592.